Are we in a paradigm shift in our #endTB response?

What Happened

A growing body of evidence and public health commentary is highlighting that India's TB elimination effort requires a dual approach — addressing both medical gaps (diagnostics, drug resistance, treatment adherence) and social determinants (malnutrition, poverty, poor housing, stigma).
India accounts for approximately 25% of all TB cases globally (WHO Global TB Report 2025), despite recording a 21% decline in incidence since 2015 — nearly double the global decline of 12%.
India's original target of TB elimination by 2025 (44 cases per 100,000) was not met; the incidence remains at 187 per 100,000.
The government's revised Nikshay Poshan Yojana (July 2024, effective November 2024) doubles nutritional support for TB patients from ₹500 to ₹1,000 per month and extends benefits to family members, reflecting the turn toward social protection.
The paradigm shift involves recognising that TB is not merely an infectious disease but also a disease of poverty — and that eliminating it requires multi-sectoral action beyond the health ministry.

Static Topic Bridges

Tuberculosis — Epidemiology and India's Burden

Tuberculosis (TB) is caused by Mycobacterium tuberculosis, an airborne bacterium that primarily affects the lungs (pulmonary TB) but can affect any organ. India bears the world's largest TB burden: 25% of global cases, 32% of drug-resistant TB (DR-TB) cases, and approximately 28% of TB-related deaths (WHO 2025). The risk of developing active TB is strongly associated with malnutrition, HIV co-infection, diabetes, crowded living conditions, and tobacco use.

TB is the leading infectious disease killer globally after COVID-19; kills approximately 1.23 million people annually (WHO 2025)
India's TB incidence: 187 per 100,000 in 2024, down from 237 in 2015 (21% decline)
Treatment success rate in India: 89-90%, above the global average of 88%
Multi-Drug Resistant TB (MDR-TB): caused by strains resistant to at least isoniazid and rifampicin (first-line drugs) — India accounts for 32% of global MDR-TB cases
Co-morbidities driving TB burden: malnutrition (~40% of cases linked to undernutrition), diabetes (India's TB-diabetes dual burden is growing), HIV
TB kills disproportionately in the 15-45 age group — the economically productive cohort

Connection to this news: India's failure to meet the 2025 elimination target, despite strong treatment outcomes, points to social determinants as the missing piece. Pure biomedical treatment addresses the bacterium; the paradigm shift recognises that poverty, malnutrition, and stigma must be addressed simultaneously.

India's National TB Elimination Programme (NTEP) and Key Schemes

India's National Tuberculosis Elimination Programme (formerly RNTCP — Revised National Tuberculosis Control Programme) is the world's largest TB control programme. It operates under a four-pillar National Strategic Plan (NSP 2017-2025): Detect, Treat, Prevent, and Build multi-sectoral responses. Key associated schemes reflect the integration of social and medical approaches.

Nikshay Poshan Yojana (NPY): Direct benefit transfer scheme for TB patients; ₹1,000/month (revised from ₹500, effective November 2024) to cover nutritional needs during treatment
Pradhan Mantri TB Mukt Bharat Abhiyaan (PMTBMBA): Community-based support scheme engaging Ni-Kshay Mitras (sponsors/benefactors) — individuals, corporates, NGOs — to support TB patients with nutrition kits, vocational training, and psychosocial support
Energy Dense Nutritional Supplementation (EDNS): For underweight TB patients (BMI < 18.5) — approximately 12 lakh patients to receive supplements during first two months of treatment
NTEP target: Eliminate TB by 2025 (missed), now targeting 2030 alongside global SDG target
Nikshay portal: Digital platform for real-time TB case notification, treatment tracking, and DBT payments; over 2.6 million cases notified in 2024

Connection to this news: The revision of Nikshay Poshan Yojana (doubling the monthly support, extending to family members) is the policy embodiment of the paradigm shift described in the article — using a cash transfer to address the social determinant (malnutrition) that the antibiotic alone cannot cure.

The World Health Organization defines social determinants of health as the non-medical factors that influence health outcomes — including income, education, housing, employment, and food security. For TB, undernutrition is the single largest modifiable risk factor, responsible for approximately 40% of cases. Poor ventilation and overcrowded housing facilitate airborne transmission. Stigma prevents timely care-seeking and treatment adherence.

Undernutrition reduces immune function, dramatically increasing the risk of latent TB infection progressing to active disease
India's double burden: simultaneously dealing with undernutrition (leading to TB vulnerability) and rising diabetes (a major TB co-morbidity)
WHO Commission on Social Determinants of Health (2008) recommended addressing structural causes of disease, not just symptoms
Multi-sectoral action on SDH requires engagement beyond the Ministry of Health: Ministry of Agriculture (food security), Ministry of Rural Development (MGNREGS for income support), Ministry of Housing (PM Awas Yojana)
Sustainable Development Goal 1 (No Poverty) and SDG 2 (Zero Hunger) are recognised as essential companions to SDG 3 (Good Health and Well-being) in TB elimination

Connection to this news: The "paradigm shift" described is essentially the application of the SDH framework to TB policy. The article's argument is that India's strong medical infrastructure (high case notification, good treatment success rates) has run into a social ceiling — further progress requires addressing the socioeconomic substrate of TB vulnerability.

Drug-Resistant TB and New Treatment Regimens

Drug-resistant TB — particularly MDR-TB (resistant to isoniazid and rifampicin) and XDR-TB (extensively drug-resistant) — poses one of the most serious challenges to global TB elimination. India accounts for 32% of global MDR-TB cases. New treatment regimens approved in recent years have reduced treatment duration from 18-24 months to 6-9 months for eligible MDR-TB patients.

BPaL regimen (Bedaquiline + Pretomanid + Linezolid): WHO-endorsed 6-month regimen for highly drug-resistant TB; India is rolling it out under NTEP
Bedaquiline: first new TB drug class in 50 years; approved in India for MDR-TB treatment
XDR-TB (Extensively Drug-Resistant): resistant to isoniazid, rifampicin, fluoroquinolones, and at least one injectable — extremely limited treatment options
India launched the BPaL regimen under NTEP in 2023, with WHO support, as part of the "End TB" acceleration strategy
Drug resistance is exacerbated by incomplete treatment adherence — itself a social determinant issue (poverty, stigma, side effects)

Connection to this news: The medical side of the paradigm shift includes deployment of new drug regimens (BPaL) to address drug resistance. But the article notes that even new drugs will fail if social factors (treatment adherence, nutrition, stigma) are not simultaneously addressed.

Key Facts & Data

India's share of global TB burden: 25% of cases, 32% of MDR-TB cases, ~28% of TB deaths (WHO Global TB Report 2025)
India's TB incidence: 187 per 100,000 in 2024, down from 237 per 100,000 in 2015 (21% decline)
Global decline in the same period: 12% — India's progress is nearly double the world average
India's 2025 elimination target: 44 cases per 100,000 — not met; target now extended to 2030
TB treatment success rate in India: 89-90% (global average: 88%)
Malnutrition accounts for approximately 40% of TB cases in India
Nikshay Poshan Yojana: revised July 2024, effective November 1, 2024 — ₹500 to ₹1,000/month per patient
EDNS (Energy Dense Nutritional Supplementation): ~12 lakh underweight TB patients to receive supplements
TB kills approximately 1.23 million people globally per year (WHO 2025)
2.6 million TB cases notified in India in 2024 (Nikshay portal data)
Pradhan Mantri TB Mukt Bharat Abhiyaan (PMTBMBA): community sponsorship programme for nutritional and psychosocial support
World TB Day: March 24 (theme 2025: "Yes! We can end TB!")